ホーム › PubMed Lab 🤖 自分の AI で使う ⭐ 保存した論文

🔬 PubMed Lab

日本語で入力するだけで、PubMed の英語論文を検索できるリサーチアシスタントです。
卒論・研究テーマ探し、興味のある論文を効率よく見つけられます。

「皮膚の常在菌が免疫を介して皮膚がんに関与か」の検索結果

535 件中 10 件を表示 (3999 ms) · ⭐ 保存した論文

AI が生成した英語クエリを見る
(skin microbiota OR skin microbiome OR cutaneous microbiota OR commensal bacteria) AND (immunity OR immune system OR immune response) AND (skin cancer OR melanoma OR cutaneous malignancy OR skin neoplasm)

💡 皮膚常在菌・マイクロバイオームと免疫応答、皮膚がんの3要素をANDで結合し、各要素に同義語をORで追加

🎓 卒論・修論テーマを AI が提案

この 5 本の論文を俯瞰して、あなたが実際に卒論・修論で研究できるテーマを 3 つ提案します。

残り 3 / 3 回 (今日)

📖 このサイトの解説記事から (日本語で読める)

PubMed Trivia が過去に取り上げた論文を日本語で解説している記事です。

🔍 PubMed の検索結果

  • Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.

    Jeffrey S Weber, Matteo S Carlino, Adnan Khattak 他 · Lancet (London, England) · 2024

    Checkpoint inhibitors are standard adjuvant treatment for stage IIB-IV resected melanoma, but many patients recur. Our study aimed to evaluate whether mRNA-4157 (V940), a novel mRNA-based individualised neoantigen therapy, combined with pembrolizumab, improved recurrence-free survival and distant metastasis-free survival versus pembrolizumab monotherapy in resected high-risk melanoma. We did an op…

    📄 PubMed で読む (PMID: 38246194)
  • The human skin microbiome.

    Allyson L Byrd, Yasmine Belkaid, Julia A Segre 他 · Nature reviews. Microbiology · 2018

    Functioning as the exterior interface of the human body with the environment, skin acts as a physical barrier to prevent the invasion of foreign pathogens while providing a home to the commensal microbiota. The harsh physical landscape of skin, particularly the desiccated, nutrient-poor, acidic environment, also contributes to the adversity that pathogens face when colonizing human skin. Despite t…

    📄 PubMed で読む (PMID: 29332945)
  • Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

    V Gopalakrishnan, C N Spencer, L Nezi 他 · Science (New York, N.Y.) · 2018

    Preclinical mouse models suggest that the gut microbiome modulates tumor response to checkpoint blockade immunotherapy; however, this has not been well-characterized in human cancer patients. Here we examined the oral and gut microbiome of melanoma patients undergoing anti-programmed cell death 1 protein (PD-1) immunotherapy (n = 112). Significant differences were observed in the diversity and com…

    📄 PubMed で読む (PMID: 29097493)
  • The human microbiome in disease and pathology.

    Jim Manos · APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2022

    This narrative review seeks to examine the relationships between bacterial microbiomes and infectious disease. This is achieved by detailing how different human host microbiomes develop and function, from the earliest infant acquisitions of maternal and environmental species through to the full development of microbiomes by adulthood. Communication between bacterial species or communities of speci…

    📄 PubMed で読む (PMID: 35393656)
  • Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer.

    Dingjiacheng Jia, Qiwen Wang, Yadong Qi 他 · Cell · 2024

    The immune checkpoint blockade (ICB) response in human cancers is closely linked to the gut microbiota. Here, we report that the abundance of commensal Lactobacillus johnsonii is positively correlated with the responsiveness of ICB. Supplementation with Lactobacillus johnsonii or tryptophan-derived metabolite indole-3-propionic acid (IPA) enhances the efficacy of CD8+ T cell-mediated αPD-1 immunot…

    📄 PubMed で読む (PMID: 38490195)
  • Skin barrier immunity and ageing.

    Emma S Chambers, Milica Vukmanovic-Stejic · Immunology · 2020

    The skin is the outermost layer of the body with an extensive surface area of approximately 1·8 m2 , and is the first line of defence against a multitude of external pathogens and environmental insults. The skin also has important homeostatic functions such as reducing water loss and contributing to thermoregulation of the body. The structure of the skin and its cellular composition work in harmon…

    📄 PubMed で読む (PMID: 31709535)
  • Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.

    Erez N Baruch, Ilan Youngster, Guy Ben-Betzalel 他 · Science (New York, N.Y.) · 2021

    The gut microbiome has been shown to influence the response of tumors to anti-PD-1 (programmed cell death-1) immunotherapy in preclinical mouse models and observational patient cohorts. However, modulation of gut microbiota in cancer patients has not been investigated in clinical trials. In this study, we performed a phase 1 clinical trial to assess the safety and feasibility of fecal microbiota t…

    📄 PubMed で読む (PMID: 33303685)
  • Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.

    Diwakar Davar, Amiran K Dzutsev, John A McCulloch 他 · Science (New York, N.Y.) · 2021

    Anti-programmed cell death protein 1 (PD-1) therapy provides long-term clinical benefits to patients with advanced melanoma. The composition of the gut microbiota correlates with anti-PD-1 efficacy in preclinical models and cancer patients. To investigate whether resistance to anti-PD-1 can be overcome by changing the gut microbiota, this clinical trial evaluated the safety and efficacy of respond…

    📄 PubMed で読む (PMID: 33542131)
  • Microbiota and prostate cancer.

    Alessandro Rizzo, Matteo Santoni, Veronica Mollica 他 · Seminars in cancer biology · 2022

    Prostate cancer remains the most frequently diagnosed non-skin malignancy in male patients, still representing one of the main causes of cancer-related death worldwide. Evidence is mounting that suggests the putative role of microbiota in the carcinogenesis as well as in modulating the efficacy and activity of anticancer treatments (e.g., chemotherapy, immune checkpoint inhibitors, targeted therap…

    📄 PubMed で読む (PMID: 34536504)
  • Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy.

    Lukas F Mager, Regula Burkhard, Nicola Pett 他 · Science (New York, N.Y.) · 2020

    Several species of intestinal bacteria have been associated with enhanced efficacy of checkpoint blockade immunotherapy, but the underlying mechanisms by which the microbiome enhances antitumor immunity are unclear. In this study, we isolated three bacterial species-Bifidobacterium pseudolongum, Lactobacillus johnsonii, and Olsenella species-that significantly enhanced efficacy of immune checkpoin…

    📄 PubMed で読む (PMID: 32792462)